Jennifer M. Johnson
Thomas Jefferson University Hospital, Jefferson University Hospitals
Papers
2
Total Citations
16
H-Index
2
About
Jennifer M. Johnson is a surgical oncologist whose research focuses on head and neck squamous cell carcinoma (HNSCC), with particular emphasis on the interplay between immunotherapy and surgical outcomes. Her most cited work, a 2023 study examining the effect of preoperative immune checkpoint inhibition on complications after surgery for primary head and neck cancer, addresses a critical gap in the literature—how neoadjuvant immunotherapy impacts postoperative morbidity. This research, which has already garnered 13 citations, provides essential safety data for an emerging treatment paradigm. Johnson also investigates treatment trends in HPV-related oropharyngeal cancer, as demonstrated by her 2021 retrospective analysis of adjuvant therapy patterns, complications, and survival outcomes. Her work is notable for bridging the gap between novel immunotherapeutic approaches and traditional surgical management, offering evidence-based guidance for clinicians navigating the rapidly evolving landscape of head and neck cancer care. By quantifying real-world outcomes and complication rates, Johnson’s research directly informs surgical decision-making and patient counseling in an era of increasingly personalized, multimodality treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2